Featured Research

from universities, journals, and other organizations

'Switched-Off' Genes Put First Chink In Colon Cell's Anti-tumor Armor

Date:
March 15, 2004
Source:
Johns Hopkins Medical Institutions
Summary:
Johns Hopkins Kimmel Cancer Center scientists have identified a switched-off family of genes that may prove to be a significant and early dent in a colon cell's anti-cancer armor.

Johns Hopkins Kimmel Cancer Center scientists have identified a switched-off family of genes that may prove to be a significant and early dent in a colon cell's anti-cancer armor. The inactivated genes, called SFRPs - for secreted frizzled-related protein - put the brake on a pathway of cell-growth genes that is an early step en route to cancer. Because the way SFRP genes are altered-through the attachment of so-called methyl groups-is reversible, the findings, reported in the March 14 advance online edition of Nature Genetics, also suggest potential anti-cancer value in green tea and other compounds that affect methylation. "SFRP could be a great target for preventing cancer," says Stephen Baylin, M.D., Ludwig Professor of Oncology and director for basic research at the Johns Hopkins Kimmel Cancer Center. A cancer cell stops the SFRP gene's brake on cell growth by attaching a methyl group to a specific portion of the gene in a process called hypermethylation. Green tea and other compounds are thought to block enzymes that control methylation.

Related Articles


SFRP genes encode proteins that, when secreted on the cell's surface, stop a chain reaction of cell growth directed by the WNT gene. WNT stands for "wingless type," which, along with SFRP genes, gets its name from characteristics of fruit flies with mutations in these genes. The WNT gene pathway has long been linked to colon cancer by scientists at the Kimmel Cancer Center and elsewhere.

"Previously, we thought that mutations downstream of the WNT gene were enough to trigger the cell to stay alive, keep growing and develop into a tumor. Our key finding is that the cell also may need to shut off SFRP genes to become cancerous," says Baylin. When Baylin's team put SFRPs back into colon cancer cells with inactivated SFRP genes and mutations in the WNT pathway, the cells stopped growing uncontrollably and died.

The research team also found that inactivation of SFRP genes occurs in the earliest form of lesion, called an atypical crypt foci (earlier than polyps or cancer). Approximately 5 percent of these lesions become colon cancers. "The colon cancer process may start by shutting off SFRP genes, which allows the WNT pathway to stay on, and these colon cells grow into atypical crypt foci," Baylin explains. "Then, some of these early lesions may acquire mutations in the WNT pathway that push the cell into growth overdrive, failure to die properly, and development into polyps and, finally, cancer."

In addition to studying natural compounds, the scientists will be investigating the prevention properties of aspirin, non-steroidal anti-inflammatory drugs, and other drugs that block methylation to determine their effect on SFRP genes.

###

This research was funded by the National Institute of Environmental Health Services.

Other participants in the research are Hiromu Suzuki, D.Neil Watkins, Kam-Wing Jair, Kornel E. Schuebel, Yoshimitsu Akiyama, Bin Yang, and James G. Herman from the Johns Hopkins Kimmel Cancer Center; Sanford D. Markowitz from the Howard Hughes Medical Institute and Case Western Reserve University, Teresa P. Pretlow and Wei-Dong Chen from Case Western Reserve, Manon van Engeland from the University of Maastricht, the Netherlands, Minoru Toyota, Takashi Tokino and Kohzoh Imai from Sapporo Medical University, and Yuji Hinoda of the Yamaguchi University School of Medicine, Japan.

The license to the MSP technique used in this research belong to OncoMethylome. Drs. Baylin and Herman serve as consultants to OncoMethylome and are entitled to royalties from any commercial use of this procedure. The terms of this arrangement are being managed by the Johns Hopkins University according to its conflict of interest policies.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "'Switched-Off' Genes Put First Chink In Colon Cell's Anti-tumor Armor." ScienceDaily. ScienceDaily, 15 March 2004. <www.sciencedaily.com/releases/2004/03/040315071202.htm>.
Johns Hopkins Medical Institutions. (2004, March 15). 'Switched-Off' Genes Put First Chink In Colon Cell's Anti-tumor Armor. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2004/03/040315071202.htm
Johns Hopkins Medical Institutions. "'Switched-Off' Genes Put First Chink In Colon Cell's Anti-tumor Armor." ScienceDaily. www.sciencedaily.com/releases/2004/03/040315071202.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins